345 related articles for article (PubMed ID: 17205531)
1. Coffee and tea consumption and risk of hepatocellular carcinoma in Italy.
Montella M; Polesel J; La Vecchia C; Dal Maso L; Crispo A; Crovatto M; Casarin P; Izzo F; Tommasi LG; Talamini R; Franceschi S
Int J Cancer; 2007 Apr; 120(7):1555-9. PubMed ID: 17205531
[TBL] [Abstract][Full Text] [Related]
2. Food groups and risk of hepatocellular carcinoma: A multicenter case-control study in Italy.
Talamini R; Polesel J; Montella M; Dal Maso L; Crispo A; Tommasi LG; Izzo F; Crovatto M; La Vecchia C; Franceschi S
Int J Cancer; 2006 Dec; 119(12):2916-21. PubMed ID: 16998792
[TBL] [Abstract][Full Text] [Related]
3. Coffee, decaffeinated coffee, tea intake, and risk of renal cell cancer.
Montella M; Tramacere I; Tavani A; Gallus S; Crispo A; Talamini R; Dal Maso L; Ramazzotti V; Galeone C; Franceschi S; La Vecchia C
Nutr Cancer; 2009; 61(1):76-80. PubMed ID: 19116877
[TBL] [Abstract][Full Text] [Related]
4. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study.
Gelatti U; Covolo L; Franceschini M; Pirali F; Tagger A; Ribero ML; Trevisi P; Martelli C; Nardi G; Donato F;
J Hepatol; 2005 Apr; 42(4):528-34. PubMed ID: 15868652
[TBL] [Abstract][Full Text] [Related]
5. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan.
Inoue M; Yoshimi I; Sobue T; Tsugane S;
J Natl Cancer Inst; 2005 Feb; 97(4):293-300. PubMed ID: 15713964
[TBL] [Abstract][Full Text] [Related]
6. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.
Bravi F; Bosetti C; Tavani A; Gallus S; La Vecchia C
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1413-1421.e1. PubMed ID: 23660416
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of related factors for primary hepatic carcinoma caused by chronic hepatitis B and hepatitis C].
Nie L; Wang XC; Niu JQ; Shang J; Han Y; Xin GJ; Jia G; Li JL; Ding GW; Liu ZF
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):546-550. PubMed ID: 28592101
[No Abstract] [Full Text] [Related]
8. Coffee, black tea and risk of gastric cancer.
Gallus S; Tramacere I; Tavani A; Bosetti C; Bertuccio P; Negri E; La Vecchia C
Cancer Causes Control; 2009 Oct; 20(8):1303-8. PubMed ID: 19430969
[TBL] [Abstract][Full Text] [Related]
9. Coffee, decaffeinated coffee, tea, and pancreatic cancer risk: a pooled-analysis of two Italian case-control studies.
Turati F; Galeone C; Talamini R; Franceschi S; Manzari M; Gallino G; Polesel J; La Vecchia C; Tavani A
Eur J Cancer Prev; 2011 Jul; 20(4):287-92. PubMed ID: 21403521
[TBL] [Abstract][Full Text] [Related]
10. Higher regular coffee and tea consumption is associated with reduced endometrial cancer risk.
McCann SE; Yeh M; Rodabaugh K; Moysich KB
Int J Cancer; 2009 Apr; 124(7):1650-3. PubMed ID: 19107932
[TBL] [Abstract][Full Text] [Related]
11. The effect of coffee consumption on the development of hepatocellular carcinoma in hepatitis B virus endemic area.
Jang ES; Jeong SH; Lee SH; Hwang SH; Ahn SY; Lee J; Park YS; Hwang JH; Kim JW; Kim N; Lee DH; Kim HY
Liver Int; 2013 Aug; 33(7):1092-9. PubMed ID: 23651110
[TBL] [Abstract][Full Text] [Related]
12. Coffee consumption and the risk of breast cancer.
Tavani A; Pregnolato A; La Vecchia C; Favero A; Franceschi S
Eur J Cancer Prev; 1998 Feb; 7(1):77-82. PubMed ID: 9511854
[TBL] [Abstract][Full Text] [Related]
13. Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study.
Bamia C; Lagiou P; Jenab M; Trichopoulou A; Fedirko V; Aleksandrova K; Pischon T; Overvad K; Olsen A; Tjønneland A; Boutron-Ruault MC; Fagherazzi G; Racine A; Kuhn T; Boeing H; Floegel A; Benetou V; Palli D; Grioni S; Panico S; Tumino R; Vineis P; Bueno-de-Mesquita HB; Dik VK; Bhoo-Pathy N; Uiterwaal CS; Weiderpass E; Lund E; Quirós JR; Zamora-Ros R; Molina-Montes E; Chirlaque MD; Ardanaz E; Dorronsoro M; Lindkvist B; Wallström P; Nilsson LM; Sund M; Khaw KT; Wareham N; Bradbury KE; Travis RC; Ferrari P; Duarte-Salles T; Stepien M; Gunter M; Murphy N; Riboli E; Trichopoulos D
Int J Cancer; 2015 Apr; 136(8):1899-908. PubMed ID: 25219573
[TBL] [Abstract][Full Text] [Related]
14. Nutrients intake and the risk of hepatocellular carcinoma in Italy.
Polesel J; Talamini R; Montella M; Maso LD; Crovatto M; Parpinel M; Izzo F; Tommasi LG; Serraino D; La Vecchia C; Franceschi S
Eur J Cancer; 2007 Nov; 43(16):2381-7. PubMed ID: 17719221
[TBL] [Abstract][Full Text] [Related]
15. Coffee and tea intake and risk of cancers of the colon and rectum: a study of 3,530 cases and 7,057 controls.
Tavani A; Pregnolato A; La Vecchia C; Negri E; Talamini R; Franceschi S
Int J Cancer; 1997 Oct; 73(2):193-7. PubMed ID: 9335441
[TBL] [Abstract][Full Text] [Related]
16. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status.
Inoue M; Kurahashi N; Iwasaki M; Shimazu T; Tanaka Y; Mizokami M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1746-53. PubMed ID: 19505908
[TBL] [Abstract][Full Text] [Related]
17. Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case-control study.
Leung WW; Ho SC; Chan HL; Wong V; Yeo W; Mok TS
J Epidemiol Community Health; 2011 Jun; 65(6):556-8. PubMed ID: 20693491
[TBL] [Abstract][Full Text] [Related]
18. Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis.
Kennedy OJ; Roderick P; Buchanan R; Fallowfield JA; Hayes PC; Parkes J
BMJ Open; 2017 May; 7(5):e013739. PubMed ID: 28490552
[TBL] [Abstract][Full Text] [Related]
19. Tea and coffee consumption and risk of oral cavity cancer: results of a large population-based case-control study, the ICARE study.
Radoï L; Paget-Bailly S; Menvielle G; Cyr D; Schmaus A; Carton M; Guida F; Cénée S; Sanchez M; Guizard AV; Velten M; Stücker I; Luce D
Cancer Epidemiol; 2013 Jun; 37(3):284-9. PubMed ID: 23453554
[TBL] [Abstract][Full Text] [Related]
20. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
Chiesa R; Donato F; Tagger A; Favret M; Ribero ML; Nardi G; Gelatti U; Bucella E; Tomasi E; Portolani N; Bonetti M; Bettini L; Pelizzari G; Salmi A; Savio A; Garatti M; Callea F
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
